Heller Frances K

Exelixis, Inc.

EVP, Business Development

Avg. Two Year Performance

No Purchase Track Record

(89%) Avg. Sale Return (37%) Compound

Holdings: 17.25K shares

Last Three Months: 25-Aug-24 -- 24-Nov-24

0 Net Amount

Buy:	0	--
Sell:	0	--

Sentiment

Company Sentiment

Biotechnology

Drugs

Two Year Chart

25-Nov-22 -- 24-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Company Sentiment

Most Recent Insider Transactions